|
Volumn 19, Issue 6, 2014, Pages 224-225
|
Randomised controlled trial: Questions linger over POISE-2 and perioperative aspirin management
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
CARDIOVASCULAR DISEASE;
DEATH;
DIABETES MELLITUS;
DRUG INDICATION;
DRUG SAFETY;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
META ANALYSIS (TOPIC);
MULTICENTER STUDY (TOPIC);
OUTCOME ASSESSMENT;
PERIOPERATIVE PERIOD;
PEROPERATIVE COMPLICATION;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE THROMBOSIS;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SECONDARY PREVENTION;
TRANSIENT ISCHEMIC ATTACK;
VASCULAR DISEASE;
CHEMICALLY INDUCED;
FEMALE;
MALE;
MORTALITY;
MYOCARDIAL INFARCTION;
POSTOPERATIVE COMPLICATIONS;
SURGERY;
ASPIRIN;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
POSTOPERATIVE COMPLICATIONS;
POSTOPERATIVE HEMORRHAGE;
SURGICAL PROCEDURES, OPERATIVE;
|
EID: 84911372570
PISSN: 13565524
EISSN: 14736810
Source Type: Journal
DOI: 10.1136/ebmed-2014-110035 Document Type: Article |
Times cited : (8)
|
References (3)
|